Inogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 04, 2022 at 04:05 pm EDT
Share
Inogen, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 103.38 million compared to USD 101.56 million a year ago. Revenue was USD 103.38 million compared to USD 101.56 million a year ago. Net loss was USD 3.44 million compared to net income of USD 5.1 million a year ago. Basic loss per share from continuing operations was USD 0.15 compared to basic earnings per share from continuing operations of USD 0.23 a year ago. Diluted loss per share from continuing operations was USD 0.15 compared to diluted earnings per share from continuing operations of USD 0.22 a year ago.
For the six months, sales was USD 183.76 million compared to USD 188.5 million a year ago. Revenue was USD 183.76 million compared to USD 188.5 million a year ago. Net loss was USD 17.66 million compared to net income of USD 4.37 million a year ago. Basic loss per share from continuing operations was USD 0.77 compared to basic earnings per share from continuing operations of USD 0.2 a year ago. Diluted loss per share from continuing operations was USD 0.77 compared to diluted earnings per share from continuing operations of USD 0.19 a year ago.
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
INOGEN, INC. 
